<DOC>
	<DOCNO>NCT00002659</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Combining one drug may kill tumor cell . It yet know treatment cisplatin plus epinephrine effective head neck cancer . PURPOSE : Randomized double-blinded phase III trial determine effectiveness cisplatin plus epinephrine injectable gel form treat patient recurrent refractory head neck cancer .</brief_summary>
	<brief_title>Cisplatin Plus Epinephrine Treating Patients With Recurrent Refractory Head Neck Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . Compare effect intratumoral injection cisplatin/epinephrine gel ( CDDP-e TI ) placebo gel local control recurrent refractory squamous cell carcinoma head neck . II . Assess achievement preselected ( investigator ) treatment goal troublesome tumor patient recurrent refractory squamous cell carcinoma head neck follow 6 weekly intratumoral treatment CDDP-e TI vs. placebo gel . III . Compare effect CDDP-e TI placebo gel total local tumor volume per patient . IV . Evaluate time response time progression troublesome tumor local treatment CDDP-e TI vs. placebo gel . V. Assess improvement stabilization quality life patient measure FACT-H &amp; N questionnaire . VI . Compare histopathology inject lesion respond local treatment . OUTLINE : Randomized , double-blind study . Randomization weight 2:1 favor Arm I . Arm I : Intratumoral Chemotherapy . Cisplatin ( NSC-119875 ) Epinephrine bovine collagen gel , MP 5010 , CDDP-e TI . Arm II : Control . NS bovine collagen gel , PLCB . PROJECTED ACCRUAL : Up 120 evaluable patient study provide 80 evaluable patient Arm I 40 evaluable patient Arm II .</detailed_description>
	<mesh_term>Carcinoma , Squamous Cell</mesh_term>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Epirubicin</mesh_term>
	<mesh_term>Epinephrine</mesh_term>
	<mesh_term>Racepinephrine</mesh_term>
	<mesh_term>Epinephryl borate</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm squamous cell carcinoma head neck recurrent refractory follow least 1 course therapy Primary metastatic tumor involve skin , node ( palpable biopsy proven ) , subcutaneous tissue , muscle allow No involvement major artery visceral organ Measurable lesion accessible direct intratumoral injection immediate risk hemorrhage embolization Most troublesome tumor ( identified investigator ) least 0.5 cc great 20 cc Smaller tumor eligible treatment efficacy assessment An improvable primary treatment goal ( palliative preventive ) troublesome tumor must identify investigator prior enrollment If multiple tumor qualify troublesome share primary physicianselected treatment goal , large tumor select Patient may also select troublesome tumor 1 palliative treatment goal tumor ( need match physicianselected tumor goal ) No fibrotic lesion ( e.g. , previously irradiate lesion subsequent disease progression ) No tumor involve threaten invade carotid major vessel PATIENT CHARACTERISTICS : Age : 18 Performance status : Karnofsky 60 % 100 % Life expectancy : At least 6 month Hematopoietic : Absolute granulocyte count great 1,000/mm3 Platelet count great 75,000/mm3 Hepatic : Not specify Renal : Creatinine great 1.5 time normal Cardiovascular : No NYHA class III/IV status No history arrhythmia would increase risk treatment Other : No hypersensitivity cisplatin , bovine collagen , epinephrine , sulfites No significant history extracranial carotid vascular disease atherosclerosis , radiation therapy previous carotid artery surgery No uncontrolled local infection treatment sit No medical psychiatric condition would preclude informed consent No pregnant nursing woman Adequate contraception require fertile patient PRIOR CONCURRENT THERAPY : More 28 day since antineoplastic therapy therapy investigational agent Fully recover side effect prior treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2007</verification_date>
	<keyword>recurrent squamous cell carcinoma lip oral cavity</keyword>
	<keyword>recurrent squamous cell carcinoma oropharynx</keyword>
	<keyword>recurrent squamous cell carcinoma nasopharynx</keyword>
	<keyword>recurrent squamous cell carcinoma hypopharynx</keyword>
	<keyword>recurrent squamous cell carcinoma larynx</keyword>
	<keyword>recurrent squamous cell carcinoma paranasal sinus nasal cavity</keyword>
</DOC>